cnspharma.comCNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments f

or brain tumors. Brain Glioblastoma Anthracyclines Blood Brain Barrier Technology Berubicin Pipeline Expanded Access Team Management BoardContact Investors Sign Up Privacy Policy Berubicin Based on human clinical trial data, our lead drug called Berubicin, which was developed at a leading U.S. comprehensive cancer center, appears to get across the blood brain barrier and kill brain tumor cells not reachable by other therapies. In other words, Berubicin may become an effective treatment against glioblastoma, the most aggressive type of brain cancer. Learn More BERUBICIN PHASE I CLINICAL TRIAL This is a scan of a patient’s glioblastoma in Berubicin’s Phase 1 clinical trial where 44% of the patients showed a clinical response. Berubicin is one of the first anthracycline’s that does not require a specific carrier to be able to cross over the blood brain barrier and get into the brain. None of the drugs that require carriers have been shown to be effective in humans. The image on the left is pre-treatment and the one on the right is 6-months post-treatment. Our Lead Drug, Berubicin, was Developed at a Leading U.S. Comprehensive Cancer Center. What is Glioblastoma? Glioblastoma is the most aggressive type of brain cancer, where the average survival is only 14 to 16 months after diagnosis – essentially a death sentence for those afflicted with it. Glioblastoma is the type of brain cancer that led to the death of Senator Ted Kennedy, Vice President Joe Biden’s son and most recently, the passing of Senator John McCain. It’s important to understand that there is currently no proven cure for this aggressive disease . Learn More What are Anthracyclines? Anthracyclines are among the most effective anticancer treatments ever developed, and have played a prominent role in the treatment of more types of cancer than any other class of chemotherapeutic agents. According to academic literature, Anthracyclines have demonstrated anti-tumor activity in a wide range of cancers including breast, stomach, uterine, ovarian, bladder, lung and hematological malignancies. Learn More What is the Blood Brain Barrier? The blood brain barrier is a protective wall of specialized endothelial cells that separate the blood from the brain tissue. The blood brain barrier was beautifully designed to protect the brain from foreign substances that could harm the brain like anthracyclines and other chemotherapy agents. Learn More Join Our Newsletter To Follow Our Progress! Sign Up Below First Name * Email * Cell (Used For Press Releases) Click to See Terms of Service. Click to See Privacy Policy. Messages and data rates may apply. Reply STOP to end or HELP for help. Terms and Conditions * You consent to us contacting you using all channels of communication and for all purposes, using all contact information you provide to us. You also consent to us and our successors (if any), using email, text messages, any automatic telephone dialing system and/or an artificial or prerecorded voice when contacting you, even if you are charged for the text message or call under your phone plan. You are responsible for any charges for contacting you that may be billed to you by your communications carriers. Δ © 2022, CNS Pharmaceuticals, Inc. All Rights Reserved. Brain Glioblastoma Anthracyclines Blood Brain Barrier Technology Berubicin Pipeline Expanded Access Team Management BoardContact Investors Sign Up Privacy...